Aclaris Therapeutics (ACRS) Operating Margin (QoQ) (2017 - 2026)
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Operating Margin (QoQ) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Aclaris Therapeutics | 879.26 Mn | 879.26 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37,608.00 |
| Mar 31, 2026 | 64,370.00 |
| Dec 31, 2025 | -123,570.00 |
| Sep 30, 2025 | 51,608.00 |
| Jun 30, 2025 | 20,698.00 |
| Mar 31, 2025 | -16,076.00 |
| Dec 31, 2024 | -84,120.00 |
| Sep 30, 2024 | 22,378.00 |
| Jun 30, 2024 | 32,474.00 |
| Mar 31, 2024 | -76,642.00 |
| Dec 31, 2023 | 31,716.00 |
| Sep 30, 2023 | 136,205.00 |
| Jun 30, 2023 | -51,878.00 |
| Mar 31, 2023 | -80,840.00 |
| Dec 31, 2022 | -26,531.00 |
| Sep 30, 2022 | 126,419.00 |
| Jun 30, 2022 | -7,271.00 |
| Mar 31, 2022 | 22,394.00 |
| Dec 31, 2021 | -30,186.00 |
| Sep 30, 2021 | -23,616.00 |